✦ LIBER ✦

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

✍ Scribed by Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Masato Koseki; Hideo Baba; Yu-Nien Sun; Koji Murakami; Toshirou Nishida

Publisher: Springer
Year: 2009
Tongue: English
Weight: 302 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1103-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety profile of imatinib

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

✍ Toshirou Nishida; Kuniaki Shirao; Akira Sawaki; Masato Koseki; Takeshi Okamura; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 258 KB

Focal progression in patients with gastr

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients

✍ Salah-Eddin Al-Batran; Joerg Thomas Hartmann; Florian Heidel; Jan Stoehlmacher; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 326 KB

Phase 1 study of the investigational, or

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB

Imatinib plus low-dose doxorubicin in pa

Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib : A phase I-II study by the Spanish group for research on sarcomas

✍ Joan Maurel; Ana Sofia Martins; Andrés Poveda; José Antonio López-Guerrero; Rica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 3 views

A two-arm phase II study of temozolomide

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas

✍ Jonathan C. Trent; Jennifer Beach; Michael A. Burgess; Nicholas Papadopolous; Le 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a two‐arm Phase II study of temozolomide to determine its efficacy and toxicity in patients with soft tissue sarcomas (STSs) who had received, had refused, or were not eligible for standard chemotherapy with doxorubicin and ifosfamide (Arm 1) and in

Phase II study of intravenous TZT-1027 i

Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy

✍ Shreyaskumar Patel; Mary Louise Keohan; M. Wasif Saif; Daniel Rushing; Luis Baez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views